Mild cognitive impairment: Transition between aging and Alzheimer's disease

Neurologia

Volumn 15, Issue 3, 2000, Pages 93-101

  Petersen, R C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aging; Alzheimer's disease; Mild cognitive impairment

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; DEMENTIA; MEMORY; NEUROFIBRILLARY TANGLE; SENILE PLAQUE;

ACTIVITIES OF DAILY LIVING; AGED; AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0034087231     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos E, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
2. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41: 1006-1009.
3. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DI, Thibodeau S et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995; 273: 1274-1278.
4. Minoshima S, Giordani B, Berent S, Frey K, Foster N, Kuhl D. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.
5. Petersen RC. Normal aging, mild cognitive impairment, and early Alzheimer's disease. The Neurologist 1995; 1: 326-344.
6. Petersen R, Smith G, Waring S, Ivnik R, Kokmen E, Tangalos E. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997; 9: 37-43.
7. Jacobs D, Sano M, Dooneief G, Marder K, Bell K, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 957-962.
8. Murphy E. The normal and the perils of the sylleptic argument. Perspect Biol Med 1972; 15: 566-582.
9. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997; 48: 1297-1304.
10. Markesbery W. Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S13-S19.
11. Morris JC, McKeel DW, Storandt M, Rubin EH, Price JL, Grant EA et al. Very mild Alzheimer's disease: informant based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991; 41: 469-478.
12. Craik F. Memory functions in normal aging. En: Yanagihara T, Petersen R, editores. Memory disorders: research and clinical practice. Nueva York: Dekker, 1991; 347-368.
13. Petersen RC, Smith G, Kokmen E, Ivnik RJ, Tangalos EG. Memory function in normal aging. Neurology 1992; 42: 396-401.
14. Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG. Memory function in very early Alzheimer's disease. Neurology 1994; 44: 867-872.
15. Fuld P, Masur D, Blau A, Crystal H, Aronson M. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. J Clin Exp Neuropsychol 1990; 539-548.
16. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E et al. Mayo's Older Americans Normative Studies: WAIS-R Norms for Ages 56 to 97. Clin Neuropsychol 1992; 6 (Supl): 1-30.
17. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42: 183-188.
18. Jack CR Jr, Petersen RC, Xu Y-C, Waring SC, O'Brien PC, Tangalos EG et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 786-794.
19. Golomb J, DeLeon M, Kluger A, George AE, Tarshish C, Ferris SH. Hippocampal atrophy in normal aging: an association with recent memory impairment. Arch Neurol 1993; 40: 967-970.
20. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41: 51-54.
21. Soininen HS, Partanen K, Pitkanen A, Vainio P, Hanninen T, Hallikainen M et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994; 44: 1660-1668.
22. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer disease. Neurology 1992; 42: 631-639.
23. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992; 42: 1681-1688.
24. Hyman BT, Van Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer's disease: an anatomical study. Neurology 1990; 40: 1721-1730.
25. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
26. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change -Report of a National Institute of Mental Health Work Group. Dev Neuropsychol 1986; 2: 261-276.
27. Smith GE, Ivnik RJ, Petersen RC, Malec JF, Kokmen E, Tangalos E. Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. Psychol Aging 1991; 6: 551-558.
28. Youngjohn J, Crook T. Stability of everyday memory in age-associated memory impairment: a longitudinal study. Neuropsychology 1993; 7: 406-416.
29. Buschke H. Cued recall in amnesia. J Clin Neurophysiol 1984; 6: 433-440.
30. Grober E, Buschke H. Genuine memory deficits in dementia. Dev Neuropsychol 1987; 3: 13-36.
31. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology 1988; 38: 900-903.
32. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991; 48: 278-281.
33. Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996; 46: 149-154.
34. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996; 46: 661-665.
35. Flicker C, Ferris S, Reisberg B. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol 1993; 6: 84-96.
36. Smith GE, Petersen RC, Parisi JE, Ivnik RJ, Kokmen E, Tangalos EG et al. Definition, course and outcome of mild cognitive impairment. Aging Neuropsychol Cognition 1996; 3: 141-147.
37. Masur D, Fuld O, Blau A, Thal L, Levin H, Aronson M. Distinguishing normal and demented elderly with the selective reminding test. J Clin Exp Neuropsychol 1989; 615-630.
38. Masur D, Fuld P, Blau A, Crystal H, Aronson M. Predicting development of dementia in the elderly with the Selective Reminding Test. J Clin Exp Neuropsychol 1990; 529-538.
39. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427-1432.
40. Goldman-Rakic P. Cortical localization of working memory. En: McGaugh J, Weinberger N, Lynch G, editores. Brain organization and memory: cells, systems, and circuits. Nueva York: Oxford University Press, 1990.
41. Goldman-Rakic P. Working memory and the mind. Sci Am 1992; 111-117.
42. Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann N Y Acad Sci 1996; 802: 58-69.
43. Lezak MD. Neuropsychological assessment. Nueva York: Oxford University Press, 1995.
44. Rey A. L'examen clinique en psychologie. París: Presses Universitaires de France, 1964.
45. Morris JC, Heyman A, Mohs RC, Hughes JP, vanBelle G, Fillenbaum G et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-1165.
46. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders IV. Washington DC, 1994.
47. McKhann G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
48. Bowen J, Teri L, Kukull W, McCormick W, McCurry S, Larson E. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349: 763-765.
49. Reisberg B, Ferris S, deLeon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 130: 1136-1139.
50. Dawe B, Procter A, Philpot M. Concepts of mild memory impairment in the elderly and their relationship to dementia-a review. Int J Gertr Psychiatry 1992; 7: 473-479.
51. Convit A, De Leon M, Golomb G, George AE, Tarshish CY, Bobinski M et al. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q 1993; 64: 371-387.
52. De Leon M, Golomb J, George A, Convit A, Tarshish C, McRae T et al. The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. Am J Neuroradiology 1993; 14: 897-906.
53. De Santi S, de Leon M, Tarshish C, Golomb J, McRae T, Kluger A et al. Selective medial and lateral temporal lobe pathology in cases at risk for AD: diagnostic role of PET. Neurobiol Aging 1994; 15: S146-S147.
54. De Leon M, Golomb J, George A, Convit A, Rusinek H, Morys J et al. Hippocampal formation atrophy: prognostic significance for Alzheimer's disease. En: Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, editores. Alzheimer's disease: advances in clinical and basic research. Nueva York: Wiley, 1993; 35-46.
55. Pearlson G, Haras GJ, Powers RE, Barta PE, Camargo EE, Chase GA et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatr 1992; 49: 402-408.
56. Soininen H, Laakso M, Helkala E, Hartikainen P, Partanen K, Vainio P et al. Volumes of hippocampus and amygdala in the MRI-based diagnosis of early Alzheimer's disease. Neurobiol Aging 1994; 15: S146.
57. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-1403.
58. Holman B, Johnson K, Gerada B, Carvalho P, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992; 33:
59. Johnson K, Kijewski M, Becker J, Garada B, Satlin A, Holman B. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993; 34: 2044-2048.
60. Weinstein H, Scheltens P, Van Royen E, Hydra A. A neuroimaging in the diagnosis of Alzheimer's disease: positron and single photon emission tonography. Clinical Neurol Neurosurg 1993; 95: 81-91.
61. Hof P, Bierer L, Perl D, Delacourte A, Buee L, Bouras C et al. Evidence of early vulnerability of the medial and inferior aspects of the temporal lobe in an 82 year old patient with preclinical signs of dementia. Arch Neurol 1992; 946-953.
62. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992; 13: 179-189.
63. Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996; 46: 707-719.
64. Morris J, McKeel D, Storandt M, Rubin E, Price J, Grant E et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging.
65. Petersen R, Parisi J, Johnson K, Waring S, Smith G. Neuropathological findings in patients with a mild cognitive impairment. Neurology 1997; 48: A104.
66. The National Institute on Aging. Consensus recommendations for the postmorten diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S1-S2.